EVOLOGIC considers itself as a partner to the industries of…, developing innovative processes for the production or degradation of a wide range of organic molecules with respect for the environment as a key consideration.

EVOLOGIC invests heavily in the development of proprietary tools for coding new metabolic pathways in genomes and for automating the directed evolution of living cultures. They forge alliances with relevant partners to exploit these new processes.

EVOLOGIC is also active in the field of isolation and improvement of biocatalysts whilst allowing its clients to retain the IPR (Intellectual Property Rights).

EVOLOGIC’s technologies offer solutions with which to conquer multi billion dollar markets, exploiting genetic and fluidic tools which differ from, yet are compatible with, the combinatorial tools of HTS and gene shuffling.


After:

EVOLOGIC is a partner and an innovator. We work hand-in-hand with our industrial partners – especially in food and in health – to develop processes for the production or degradation of a wide range of organic molecules.

Our success comes from astute investment in the development of proprietary tools for coding new metabolic pathways in genomes, and for automating the directed evolution of living cultures. By forging alliances with relevant partners, we can exploit these new processes to the full.

We are also active in the isolation and improvement of biocatalysts. Our partners in this field benefit twice: from the technology itself, and from the retention of their intellectual property (IP) rights in those biocatalysts.